Alanine substitution in the C terminus of A chain alters the
receptor-activation activity of RLN2. A, schematic representation
of RLN2 mutants with alanine substitution at five different positions of the A
chain (RLN2 TA16A, RLN2 KA17A, RLN2 RA18A,
RLN2A19-20, and RLN2A22-23). B, stimulation of
cAMP production in LGR7- and LGR8-expressing cells by the wild type and mutant
RLN2 peptides. Unlike the wild type peptide, RLN2 TA16A and RLN2
KA17A mutants exhibited a significantly enhanced LGR8-activation
activity. C, competitive LGR7- and LGR8-binding assays of wild type
and mutant RLN2 peptides. Each data point in the receptor-activation and
receptor-binding assays represents the mean ± S.E. of quadruplicate and
triplicate samples, respectively.